Business Description

Description
Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.
Name Current Vs Industry Vs History
Cash-To-Debt 15.91
Equity-to-Asset -7.08
Debt-to-Equity -0.01
Debt-to-EBITDA -0.01
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 36.8
9-Day RSI 47.22
14-Day RSI 53.47
6-1 Month Momentum % 150
12-1 Month Momentum % -36.44

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.1
Quick Ratio 0.1
Cash Ratio 0.1

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 0.11
Name Current Vs Industry Vs History
ROA % -769.35
ROIC % -446.89
ROC (Joel Greenblatt) % -3830.74

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -14.15
EV-to-EBITDA -14.42
EV-to-FCF -23.14
Earnings Yield (Greenblatt) % -7.07
FCF Yield % -4.29